Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
09/2004
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/15/2004EP1457548A1 Oxazines as such and as dispersants in lubricating compositions
09/15/2004EP1456185A1 (1.2)-oxazin-3,5-diones
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004CN1528754A Beta-hydroxy-alpha-amino acid and its derivatives and synthesizing method for preparing template
09/15/2004CN1528753A Morpholol with medicinal activity
09/15/2004CN1166646C Process for synthesis of azacyclic compounds
09/10/2004WO2004076429A1 Ethynyl derivatives serving as factor xa inhibitors
09/10/2004CA2517391A1 Ethynyl derivatives serving as factor xa inhibitors
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004DE10308907A1 Ethynylderivate Ethynylderivate
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/08/2004EP1147216B1 Resorufin derivatives as substrates for cyp3a4
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1526700A Synthesis of Important intermediate for mosapride citrate
09/08/2004CN1526689A Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate
09/08/2004CN1165529C Amino-and Hydroxysubstituted triphenyl-S-triazines as stabilizers
09/07/2004US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles
09/07/2004US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
09/02/2004WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/02/2004CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/01/2004EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
09/01/2004EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
09/01/2004EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
09/01/2004EP0942729B1 Use of nk-1 receptor antagonists for treating stress disorders
09/01/2004EP0827499B1 Process for producing 5,6-dihydro-1,3-oxazines
09/01/2004CN1525959A Muller Klaus-helmut
08/2004
08/26/2004WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
08/26/2004WO2004072054A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
08/26/2004WO2004071389A2 Non-steroidal infalmmation inhibitors
08/26/2004DE10305784A1 3-Oxo-3,4-dihydro-2H-benz-(1,4)-oxazin-6-yl)-propionic acid derivative preparation, for use as integrin inhibitors with e.g. antitumor action, by multi-stage process giving diastereomerically pure product
08/25/2004EP1448537A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
08/25/2004EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade
08/25/2004CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
08/25/2004CN1163490C Method for preparing cyclic thioamide compound
08/19/2004WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors
08/19/2004WO2004069823A1 Inhibitors of histone deacetylase
08/19/2004WO2004048335A3 Mandelic acid derivatives
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162329 Structural carotenoid analogs for the inhibition and amelioration of disease
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/18/2004EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
08/18/2004EP1446390A2 Photochromic oxazine compounds and methods for their manufacture
08/17/2004US6777580 Treating 1-(3,5- bis(trifluoromethyl)phenyl)ethan-1-one with bis((pentamethylcyclopentadienyl)rhodium chloride) and (s,r)-cis-1-amino-2-hydroxy-indane in the presence of isopropanol
08/17/2004US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails
08/17/2004US6777409 For therapy of inflammation
08/12/2004WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/12/2004WO2004067519A1 Nile red light-emitting compound, method for producing nile red light-emitting compound, and light-emitting device
08/12/2004US20040158061 Reaction of (di)amines in the presence of a lysine oxidase and of a reducing agent
08/12/2004US20040157866 Amide compounds
08/11/2004EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
08/11/2004EP1154988B1 Mevinolin derivatives
08/11/2004CN1519230A Process of preparing cyclic thioacid amide compound
08/10/2004US6774232 For use in high transparency applications; to prevent degradation caused by sunlight and other sources of ultraviolet (uv) radiation of polymeric materials
08/05/2004WO2004065369A1 Carboxamide derivatives and their use as factor xa inhibitors
08/05/2004WO2004065351A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
08/05/2004US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/05/2004CA2514100A1 Carboxamide derivatives and the use thereof as factor xa inhibitors
08/05/2004CA2513349A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
08/04/2004CN1518541A Phenyl derivatives
08/04/2004CN1518463A Safety shield system for prefilled syringes
08/03/2004US6770668 Pharmaceutically active compounds and methods of use
07/2004
07/29/2004WO2004063178A1 Process for the preparation of antidiabetic phenoxazine compounds
07/29/2004WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004WO2004062586A2 Antineoplastic ether lipid compounds
07/29/2004US20040147739 Novel anti-infectives
07/29/2004US20040147513 New medicaments for the treatment of chronic obstructive pulmonary disease
07/29/2004US20040147455 Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
07/29/2004US20040146746 Diphenyl anthracene derivatives and organic electroluminescent device employing the same
07/29/2004DE19949237B4 Vorstufenverbindung für Radiodiagnostika und Verfahren zu ihrer Herstellung Precursor for radio diagnostics and process for their preparation
07/29/2004DE10302500A1 New carboxamide derivatives useful as factor Xa or VIIa inhibitors e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation, stroke and angina
07/29/2004CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/28/2004CN1516587A Quinazoline derivatives capable of promoting release of parathyroid
07/27/2004CA2177753C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
07/27/2004CA2124136C Method for producing benzylidene derivatives
07/27/2004CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
07/22/2004US20040142953 Inhibitors of histone deacetylase
07/22/2004US20040142928 particularly against herpes viruses
07/22/2004US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process.
07/21/2004EP1438352A1 Low color, low sodium benzoxazinone uv absorbers and process for making same
07/21/2004EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/21/2004CN1514829A Novel herbicides
07/20/2004US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
07/20/2004US6765009 1,4-Disubstituted benzo-fused compounds
07/15/2004WO2004058733A1 Non-steroidal anti-inflammatory agents
07/15/2004US20040137273 Red color emitting compounds for organic electroluminescent device and an organic electroluminescent device using them
07/14/2004EP1436335A1 Method for crosslinking hydrogels with morpholine-2,3-diones
07/14/2004EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
07/14/2004EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
07/14/2004EP1435785A1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests
07/14/2004EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/14/2004CN1511830A Compound used as antiphlogistic
07/14/2004CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders
07/13/2004US6762034 Resorufin derivatives as substrates for CYP3A4
07/08/2004US20040132809 Cell adhesion inhibitors
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 112